Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
7 "Kyungsik Kim"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Review Article
Thyroid
2025 Korean Thyroid Association Clinical Management Guideline on Active Surveillance for Low-Risk Papillary Thyroid Carcinoma
Eun Kyung Lee, Min Joo Kim, Seung Heon Kang, Bon Seok Koo, Kyungsik Kim, Mijin Kim, Bo Hyun Kim, Ji-hoon Kim, Shinje Moon, Kyorim Back, Young Shin Song, Jong-hyuk Ahn, Hwa Young Ahn, Ho-Ryun Won, Won Sang Yoo, Min Kyoung Lee, Jeongmin Lee, Ji Ye Lee, Kyong Yeun Jung, Chan Kwon Jung, Yoon Young Cho, Dong-Jun Lim, Sun Wook Kim, Young Joo Park, Dong Gyu Na, Jee Soo Kim
Endocrinol Metab. 2025;40(3):307-341.   Published online June 24, 2025
DOI: https://doi.org/10.3803/EnM.2025.2461
  • 19,428 View
  • 637 Download
  • 9 Web of Science
  • 9 Crossref
AbstractAbstract PDFPubReader   ePub   
The increasing detection of papillary thyroid microcarcinoma (PTMC) has raised concerns regarding overtreatment. For low-risk PTMC, either immediate surgery or active surveillance (AS) can be considered. To facilitate the implementation of AS, the Korean Thyroid Association convened a multidisciplinary panel and developed the first Korean guideline. AS is recommended for adults with pathologically confirmed Bethesda V–VI PTMC who have no clinical evidence of lymph node or distant metastasis, gross extrathyroidal extension, invasion of the trachea or recurrent laryngeal nerve, or aggressive histology. A baseline assessment requires high-resolution neck ultrasound performed by experienced operators to exclude extrathyroidal extension, tracheal or recurrent laryngeal nerve invasion, and lymph node metastasis; contrast-enhanced neck computed tomography is optional. Patient characteristics, including age, comorbidities, and the capacity for long-term follow-up, should be thoroughly assessed. Shared decision-making should carefully weigh the benefits and risks of surgery versus AS, considering expected oncologic outcomes, potential complications, quality of life, anxiety, medical costs, and patient preference. Follow-up involves neck ultrasound and thyroid function tests every 6 months for 2 years and annually thereafter. Disease progression, defined as significant tumor growth or newly detected nodal or distant metastasis, warrants surgery. Despite remaining uncertainties, this guideline provides a structured framework to ensure oncologic safety and supports patient-centered AS.

Citations

Citations to this article as recorded by  
  • Feasibility and Safety of Active Surveillance in Subcapsular Thyroid Nodules with High Suspicion for Malignancy
    Yan Hu, Wei Zhou, Lu Zhang, Weiwei Zhan
    Ultrasound in Medicine & Biology.2026; 52(4): 816.     CrossRef
  • Combined Ultrasound and MRI Assessment in Patients Undergoing Reoperation for Recurrent Papillary Thyroid Carcinoma: Oncological Outcomes and Surgical Safety
    Zimei Tang, Jie Liu, Rong Wang, Gang Tian, Anwen Ren, Jiexiao Li, Yiran Wang, Wen Yang, Peng Sun, Tao Huang, Ximeng Zhang, Jie Ming
    Current Oncology.2026; 33(2): 98.     CrossRef
  • Multidisciplinary team diagnosis and treatment of well-differentiated thyroid carcinoma: current landscape and future prospects
    Yuanyuan Li, Peijie Wang, Jiaxin Cao, Haiyan Liu
    The Oncologist.2026;[Epub]     CrossRef
  • Controlled minimally invasive surgical interventions for the treatment of patients with thyroid carcinoma
    David D. Dolidze, Zurab A. Bagatelia, Suren G. Laboyan, Arshak V. Vardanyan, Konstantin S. Titov, Ivan N. Lebedinsky, Georgi Genadi Melkonyan, Dmitriy V. Matveev, Nodar N. Gogitidze, Andrei Y. Lukin, Armen R. Oganyan, David G. Gogolashvili, Anastasia V. B
    Journal of Experimental and Clinical Surgery.2026; 19(1): 45.     CrossRef
  • Overdiagnosis and Overtreatment of Thyroid Cancer and Precision Mitigation Strategies—An Integrated Analysis Based on Evidence-Based Medicine and Risk Stratification Models
    云菲 李
    Advances in Clinical Medicine.2026; 16(04): 4980.     CrossRef
  • Active surveillance for low-risk papillary thyroid carcinoma: Integrating guidelines, emerging evidence, and directions
    Zijing Wu, Kaiang Zhang, Huixian Zhou, Leyi Wan, Jingyuan Zhong, Chunhua Li, Lianggeng Gong, Yun Peng
    iScience.2026; 29(6): 115832.     CrossRef
  • Prognostic Factors and Recurrence in Papillary Thyroid Microcarcinoma
    Aydan Farzaliyeva, Feride Pınar Altay, Ozlem Turhan Iyidir, Neslihan Bascil Tutuncu
    Medicina.2026; 62(5): 981.     CrossRef
  • Optimal cutoff value of fine-needle aspiration thyroglobulin of metastatic lymph node in thyroid cancer patients
    Yang Yang, Xianfeng Jiang
    European Journal of Surgical Oncology.2025; 51(11): 110428.     CrossRef
  • Low-risk thyroid cancer: surgery or active surveillance—an application of shared decision-making: a narrative review
    Min Joo Kim, Eun Kyung Lee, Sun Wook Cho, Yoo Hyung Kim, Kyu Eun Lee, Su-jin Kim, Woochul Kim, Eun-Jae Chung, Jungirl Seok, Yul Hwangbo, Young Ki Lee, Jinsun Jang, Junsun Ryu, Yuh-Seog Jung, Chang Hwan Ryu, Jae Hoon Moon, June Young Choi, Hyeong Won Yu, K
    Journal of the Korean Medical Association.2025; 68(9): 573.     CrossRef
Close layer
Original Articles
Thyroid
Study Protocol of Expanded Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro-EXP)
Jae Hoon Moon, Eun Kyung Lee, Wonjae Cha, Young Jun Chai, Sun Wook Cho, June Young Choi, Sung Yong Choi, A Jung Chu, Eun-Jae Chung, Yul Hwangbo, Woo-Jin Jeong, Yuh-Seog Jung, Kyungsik Kim, Min Joo Kim, Su-jin Kim, Woochul Kim, Yoo Hyung Kim, Chang Yoon Lee, Ji Ye Lee, Kyu Eun Lee, Young Ki Lee, Hunjong Lim, Do Joon Park, Sue K. Park, Chang Hwan Ryu, Junsun Ryu, Jungirl Seok, Young Shin Song, Ka Hee Yi, Hyeong Won Yu, Eleanor White, Katerina Mastrocostas, Roderick J. Clifton-Bligh, Anthony Glover, Matti L. Gild, Ji-hoon Kim, Young Joo Park
Endocrinol Metab. 2025;40(2):236-246.   Published online February 18, 2025
DOI: https://doi.org/10.3803/EnM.2024.2136
  • 7,946 View
  • 182 Download
  • 5 Web of Science
  • 4 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Active surveillance (AS) has emerged as a viable management strategy for low-risk papillary thyroid microcarcinoma (PTMC), following pioneering trials at Kuma Hospital and the Cancer Institute Hospital in Japan. Numerous prospective cohort studies have since validated AS as a management option for low-risk PTMC, leading to its inclusion in thyroid cancer guidelines across various countries. From 2016 to 2020, the Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro) enrolled 1,177 patients, providing comprehensive data on PTMC progression, sonographic predictors of progression, quality of life, surgical outcomes, and cost-effectiveness when comparing AS to immediate surgery. The second phase of MAeSTro (MAeSTro-EXP) expands AS to low-risk papillary thyroid carcinoma (PTC) tumors larger than 1 cm, driven by the hypothesis that overall risk assessment outweighs absolute tumor size in surgical decision-making.
Methods
This protocol aims to address whether limiting AS to tumors smaller than 1 cm may result in unnecessary surgeries for low-risk PTCs detected during their rapid initial growth phase. By expanding the AS criteria to include tumors up to 1.5 cm, while simultaneously refining and standardizing the criteria for risk assessment and disease progression, we aim to minimize overtreatment and maintain rigorous monitoring to improve patient outcomes.
Conclusion
This study will contribute to optimizing AS guidelines and enhance our understanding of the natural course and appropriate management of low-risk PTCs. Additionally, MAeSTro-EXP involves a multinational collaboration between South Korea and Australia. This cross-country study aims to identify cultural and racial differences in the management of low-risk PTC, thereby enriching the global understanding of AS practices and their applicability across diverse populations.

Citations

Citations to this article as recorded by  
  • Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer: Protocol of a Multicenter Cluster-Randomized Trial (MAeSTro-SDM)
    Eun Kyung Lee, Min Joo Kim, Yul Hwangbo, Jae Hoon Moon, Sun Wook Cho, Young Jun Chai, June Young Choi, Yuh-Seog Jung, Kyu Eun Lee, Eun-Jae Chung, Kyungsik Kim, Su-jin Kim, Woochul Kim, Yoo Hyung Kim, Young Ki Lee, Jinsun Jang, Young Shin Song, Ka Hee Yi,
    Journal of Korean Medical Science.2026;[Epub]     CrossRef
  • Study Protocol of Expanded Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro-EXP) (Endocrinol Metab 2025;40:236-46, Jae Hoon Moon et al.)
    Eun Kyung Lee, Jae Hoon Moon, Young Joo Park
    Endocrinology and Metabolism.2025; 40(4): 655.     CrossRef
  • Study Protocol of Expanded Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro-EXP) (Endocrinol Metab 2025;40:236-46, Jae Hoon Moon et al.)
    Hoonsung Choi
    Endocrinology and Metabolism.2025; 40(4): 653.     CrossRef
  • Habitat imaging combined with multimodal analysis for preoperative risk stratification of papillary thyroid carcinoma
    Jia-Wei Feng, You-Long Zhu, Lu Zhang, Yu-Xin Yang, An-Cheng Qin, Shui-Qing Liu, Yong Jiang
    Insights into Imaging.2025;[Epub]     CrossRef
Close layer
Diabetes, obesity and metabolism
Comparison of Population Attributable Fractions of Cancer Incidence and Mortality Linked to Excess Body Weight in Korea from 2015 to 2030
Youjin Hong, Jihye An, Jeehi Jung, Hyeon Sook Lee, Soseul Sung, Sungji Moon, Inah Kim, Jung Eun Lee, Aesun Shin, Sun Ha Jee, Sun-Seog Kweon, Min-Ho Shin, Sangmin Park, Seung-Ho Ryu, Sun Young Yang, Seung Ho Choi, Jeongseon Kim, Sang-Wook Yi, Yoon-Jung Choi, Sangjun Lee, Woojin Lim, Kyungsik Kim, Sohee Park, Jeong-Soo Im, Hong Gwan Seo, Kwang-Pil Ko, Sue K. Park
Endocrinol Metab. 2024;39(6):921-931.   Published online November 28, 2024
DOI: https://doi.org/10.3803/EnM.2024.2071
  • 6,151 View
  • 115 Download
  • 4 Web of Science
  • 5 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
The increasing rate of excess body weight (EBW) in the global population has led to growing health concerns, including cancer-related EBW. We aimed to estimate the population attributable fraction (PAF) of cancer incidence and deaths linked to EBW in Korean individuals from 2015 to 2030 and to compare its value with various body mass index cutoffs.
Methods
Levin’s formula was used to calculate the PAF; the prevalence rates were computed using the Korean National Health and Nutrition Examination Survey data, while the relative risks of specific cancers related to EBW were estimated based on the results of Korean cohort studies. To account for the 15-year latency period when estimating the PAF in 2020, the prevalence rates from 2015 and attributable cases or deaths from 2020 were used.
Results
The PAF attributed to EBW was similar for both cancer incidence and deaths using either the World Health Organization (WHO) Asian-Pacific region standard or a modified Asian standard, with the WHO standard yielding the lowest values. In the Korean population, the PAFs of EBW for cancer incidence were 2.96% in men and 3.61% in women, while those for cancer deaths were 0.67% in men and 3.06% in women in 2020. Additionally, PAFs showed a gradual increase in both sexes until 2030.
Conclusion
The EBW continues to have a significant impact on cancer incidence and deaths in Korea. Effective prevention strategies targeting the reduction of this modifiable risk factor can substantially decrease the cancer burden.

Citations

Citations to this article as recorded by  
  • Over one‐third of cancer cases and two‐fifths of cancer deaths in southern China are preventable: Insights from the latest representative population‐based cancer registry data and risk factor survey
    Xiaolan Wen, Yu Liao, Jiayue Li, Qian Zhu, Xinmei Lin, Bingfeng Han, Li Li, Ru Chen, Ruilin Meng, Ni Xiao, Xueyan Zheng, Xiaojun Xu, Dejian Zhao, Yue Gao, Liming Pu, Ye Wang, Wenqiang Wei, Shaoming Wang
    International Journal of Cancer.2026; 158(4): 909.     CrossRef
  • Application and interpretation of attributable fraction measures from clinical practice to policy: a narrative review
    Sue Kyung Park
    Journal of the Korean Medical Association.2026; 69(5): 411.     CrossRef
  • Cancer attributable to excess body weight in Korea: a focus on primary prevention
    Yoon-Jung Choi
    Journal of the Korean Medical Association.2025; 68(2): 100.     CrossRef
  • Population attributable fraction as a key measure of primary cancer prevention strategy
    Sohee Park, Yoon-Jung Choi, Sue Kyung Park, Hong Gwan Seo
    Journal of the Korean Medical Association.2025; 68(2): 82.     CrossRef
  • Fraction of cancer incidence and mortality attributable to dietary factors in Korea from 2015 to 2030
    Hyun Jeong Cho, Jin Young Yoo, Ga-Eun Yie, An Na Kim, Soseul Sung, Sungji Moon, Youjin Hong, Sangjun Lee, Inah Kim, Kwang-Pil Ko, Sun-Seog Kweon, Jung Eun Lee, Sue K. Park
    Epidemiology and Health.2025; 47: e2025065.     CrossRef
Close layer
Review Articles
Thyroid
Active Surveillance for Low-Risk Thyroid Cancers: A Review of Current Practice Guidelines
Min Joo Kim, Jae Hoon Moon, Eun Kyung Lee, Young Shin Song, Kyong Yeun Jung, Ji Ye Lee, Ji-hoon Kim, Kyungsik Kim, Sue K. Park, Young Joo Park
Endocrinol Metab. 2024;39(1):47-60.   Published online February 15, 2024
DOI: https://doi.org/10.3803/EnM.2024.1937
  • 29,623 View
  • 1,005 Download
  • 36 Web of Science
  • 45 Crossref
AbstractAbstract PDFPubReader   ePub   
The indolent nature and favorable outcomes associated with papillary thyroid microcarcinoma have prompted numerous prospective studies on active surveillance (AS) and its adoption as an alternative to immediate surgery in managing low-risk thyroid cancer. This article reviews the current status of AS, as outlined in various international practice guidelines. AS is typically recommended for tumors that measure 1 cm or less in diameter and do not exhibit aggressive subtypes on cytology, extrathyroidal extension, lymph node metastasis, or distant metastasis. To determine the most appropriate candidates for AS, factors such as tumor size, location, multiplicity, and ultrasound findings are considered, along with patient characteristics like medical condition, age, and family history. Moreover, shared decision-making, which includes patient-reported outcomes such as quality of life and cost-effectiveness, is essential. During AS, patients undergo regular ultrasound examinations to monitor for signs of disease progression, including tumor growth, extrathyroidal extension, or lymph node metastasis. In conclusion, while AS is a feasible and reliable approach for managing lowrisk thyroid cancer, it requires careful patient selection, effective communication for shared decision-making, standardized follow-up protocols, and a clear definition of disease progression.

Citations

Citations to this article as recorded by  
  • Active Surveillance for Locoregional Recurrent Differentiated Thyroid Cancer: A Systematic Review and Meta-Analysis
    Hunjong Lim, Se Jin Cho, Jung Hwan Baek
    Thyroid®.2026; 36(2): 121.     CrossRef
  • Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer: Protocol of a Multicenter Cluster-Randomized Trial (MAeSTro-SDM)
    Eun Kyung Lee, Min Joo Kim, Yul Hwangbo, Jae Hoon Moon, Sun Wook Cho, Young Jun Chai, June Young Choi, Yuh-Seog Jung, Kyu Eun Lee, Eun-Jae Chung, Kyungsik Kim, Su-jin Kim, Woochul Kim, Yoo Hyung Kim, Young Ki Lee, Jinsun Jang, Young Shin Song, Ka Hee Yi,
    Journal of Korean Medical Science.2026;[Epub]     CrossRef
  • Feasibility and Safety of Active Surveillance in Subcapsular Thyroid Nodules with High Suspicion for Malignancy
    Yan Hu, Wei Zhou, Lu Zhang, Weiwei Zhan
    Ultrasound in Medicine & Biology.2026; 52(4): 816.     CrossRef
  • Radiofrequency Ablation for Primary Thyroid Cancer
    Iram Hussain
    Endocrine Practice.2026;[Epub]     CrossRef
  • De-escalation strategies in the management of differentiated thyroid cancer
    Mubeen Hussein Arawker, Fitrat Habibullah, Shantanu Baral, Lijun Fu, Ning Sun, Hongting Li, Xinguang Qiu
    Endocrine.2026;[Epub]     CrossRef
  • Current Challenges in Imaging-Based Cancer Screening, From the AJR Special Series on Screening
    Lars J. Grimm, Danielle E. Kruse, Tina D. Tailor, Karen S. Johnson, Brian C. Allen, Marc D. Ryser
    American Journal of Roentgenology.2026;[Epub]     CrossRef
  • Controlled minimally invasive surgical interventions for the treatment of patients with thyroid carcinoma
    David D. Dolidze, Zurab A. Bagatelia, Suren G. Laboyan, Arshak V. Vardanyan, Konstantin S. Titov, Ivan N. Lebedinsky, Georgi Genadi Melkonyan, Dmitriy V. Matveev, Nodar N. Gogitidze, Andrei Y. Lukin, Armen R. Oganyan, David G. Gogolashvili, Anastasia V. B
    Journal of Experimental and Clinical Surgery.2026; 19(1): 45.     CrossRef
  • Radiofrequency Ablation in the Management of Papillary Thyroid Carcinoma: Literature Review
    V. A. Solovov, A. A. Fedulov
    Creative surgery and oncology.2026; 16(1): 62.     CrossRef
  • Active Surveillance in Papillary Thyroid Cancer With Primary Tumors Greater Than 1.5 cm
    Lina Pedraza Sanchez, Justin Hintze, Samantha K. Newman, Ashok Shaha, Luc G. Morris, R. Michael Tuttle
    Head & Neck.2026;[Epub]     CrossRef
  • Active Surveillance Versus Surgery for Low-risk Well-differentiated Thyroid Cancer
    Anthony T. Saxton, Randall P. Scheri
    Advances in Surgery.2026; 60(1): 115.     CrossRef
  • Overdiagnosis and Overtreatment of Thyroid Cancer and Precision Mitigation Strategies—An Integrated Analysis Based on Evidence-Based Medicine and Risk Stratification Models
    云菲 李
    Advances in Clinical Medicine.2026; 16(04): 4980.     CrossRef
  • Active surveillance of highly suspicious thyroid nodules in the isthmus compared with non-isthmus locations: a multicenter retrospective study
    Yan Hu, Wei Zhou, Cheng Li, Lu Zhang, Weiwei Zhan
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Active surveillance for low-risk papillary thyroid carcinoma: Integrating guidelines, emerging evidence, and directions
    Zijing Wu, Kaiang Zhang, Huixian Zhou, Leyi Wan, Jingyuan Zhong, Chunhua Li, Lianggeng Gong, Yun Peng
    iScience.2026; 29(6): 115832.     CrossRef
  • Thermal Ablation for Low-Risk Papillary Thyroid Microcarcinoma in the Era of Active Surveillance: A Critical Narrative Review
    Zheng Han, Changzai Li, Hongcheng Zhu
    Current Surgery Reports.2026;[Epub]     CrossRef
  • Prognostic Factors and Recurrence in Papillary Thyroid Microcarcinoma
    Aydan Farzaliyeva, Feride Pınar Altay, Ozlem Turhan Iyidir, Neslihan Bascil Tutuncu
    Medicina.2026; 62(5): 981.     CrossRef
  • Impact of Poloxamer/Alginate (Guardix-SGⓇ) Volume on Drainage after Thyroid Lobectomy
    Seok-Kyung Kang, Miri Ryu, Meehyun Lee, Hye Won Kim, Han Pyo Hong, Seungju Lee
    International Journal of Thyroidology.2026; 19(1): 78.     CrossRef
  • Management of Differentiated Thyroid Cancer
    Laszlo Hegedüs, Lori J. Wirth, R. Michael Tuttle
    New England Journal of Medicine.2026; 394(23): 2340.     CrossRef
  • BRAF Mutation and Tumor Growth Kinetics during Active Surveillance of Papillary Thyroid Microcarcinoma: A Single-Center Retrospective Study
    Jinyoung Kim, Min Kyoung Lee, Tae-Jung Kim, Dong-Jun Lim, Ki-Hyun Baek
    Endocrinology and Metabolism.2026; 41(3): 461.     CrossRef
  • Proteomic Analysis of Tissue Proteins Related to Lateral Lymph Node Metastasis in Papillary Thyroid Microcarcinoma
    Qiyao Zhang, Zhen Cao, Yuanyang Wang, Hao Wu, Zejian Zhang, Ziwen Liu
    Journal of Proteome Research.2025; 24(1): 256.     CrossRef
  • Active Surveillance of Papillary Thyroid Cancer—A Feasibility Experience from a Tertiary Care Centre
    Narmada Nangadda, Hetashvi Gondaliya, Deepali Bhat, Anirudh J. Shetty, Kranti S. Khadilkar, Shivaprasad Kumbenahalli Siddegowda, Basavaraj G. Sooragonda, Vijay Pillai, Vidhya Bhushan Rangappa, Vivek Shetty, Yogesh Madhav Dokhe, Trupti C. Kolur, Naveen Ban
    Indian Journal of Surgical Oncology.2025; 16(3): 743.     CrossRef
  • Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Thyroid Cancer
    Sang Yi Moon, Minkook Son, Jung-Hwan Cho, Hye In Kim, Ji Min Han, Ji Cheol Bae, Sunghwan Suh
    Thyroid®.2025; 35(1): 79.     CrossRef
  • Navigating Active Surveillance for Low-Risk PTMC by Standardizing Ultrasound Evaluation: Key Takeaways from the Latest Korean Society of Thyroid Radiology Consensus Statements
    Young Joo Park
    Clinical Thyroidology®.2025; 37(1): 27.     CrossRef
  • Assessing the Rise in Papillary Thyroid Cancer Incidence: A 38-Year Australian Study Investigating WHO Classification Influence
    Steven Weller, Cordia Chu, Alfred King-yin Lam
    Journal of Epidemiology and Global Health.2025;[Epub]     CrossRef
  • A Personalized, Risk-Based Approach to Active Surveillance for Prostate Cancer with Takeaways from Broader Oncology Practices: A Mixed Methods Review
    Jeroen J. Lodder, Sebastiaan Remmers, Roderick C. N. van den Bergh, Arnoud W. Postema, Pim J. van Leeuwen, Monique J. Roobol
    Journal of Personalized Medicine.2025; 15(3): 84.     CrossRef
  • Exploration of immunocytochemical biomarkers related to central lymph node metastasis in papillary thyroid microcarcinoma
    Lulu Rong, Jie Wang, Qian Wang, Yanli Zhu, Wenhao Ren
    Cytojournal.2025; 22: 18.     CrossRef
  • Study Protocol of Expanded Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro-EXP)
    Jae Hoon Moon, Eun Kyung Lee, Wonjae Cha, Young Jun Chai, Sun Wook Cho, June Young Choi, Sung Yong Choi, A Jung Chu, Eun-Jae Chung, Yul Hwangbo, Woo-Jin Jeong, Yuh-Seog Jung, Kyungsik Kim, Min Joo Kim, Su-jin Kim, Woochul Kim, Yoo Hyung Kim, Chang Yoon Le
    Endocrinology and Metabolism.2025; 40(2): 236.     CrossRef
  • 2024 International Expert Consensus on US-guided Thermal Ablation for T1N0M0 Papillary Thyroid Cancer
    Zhen-long Zhao, Shu-rong Wang, Jennifer Kuo, Bülent Çekiç, Lei Liang, Hossam Arafa Ghazi, Shu-hang Xu, Gerardo Amabile, Song-song Wu, Ajit Yadav, Gang Dong, Ingo Janssen, Bo-qiang Fan, Nobuhiro Fukunari, Jun-feng He, Le Thanh Dung, Song-yuan Yu, Sum Leong
    Radiology.2025;[Epub]     CrossRef
  • Ultrasound and gene-guided microwave ablation vs. surgery for low-risk papillary thyroid carcinoma: a prospective observational cohort study
    Yunfang Yu, Yuxin Shen, Yujie Tan, Yisikandaer Yalikun, Tian Tian, Qingqing Tang, Qiyun Ou, Yue Zhu, Miaoyun Long
    Precision Clinical Medicine.2025;[Epub]     CrossRef
  • Global research landscape on active surveillance for papillary thyroid microcarcinoma: a bibliometric analysis
    Dong-Shu Kang, Yu-Hao Lin, Jian-Qing Tian
    Discover Oncology.2025;[Epub]     CrossRef
  • 2025 Korean Thyroid Association Clinical Management Guideline on Active Surveillance for Low-Risk Papillary Thyroid Carcinoma
    Eun Kyung Lee, Min Joo Kim, Seung Heon Kang, Bon Seok Koo, Kyungsik Kim, Mijin Kim, Bo Hyun Kim, Ji-hoon Kim, Shin Je Moon, Kyorim Back, Young Shin Song, Jong-hyuk Ahn, Hwa Young Ahn, Ho-Ryun Won, Won Sang Yoo, Min Kyoung Lee, Jeongmin Lee, Ji Ye Lee, Kyo
    International Journal of Thyroidology.2025; 18(1): 30.     CrossRef
  • 2025 Korean Thyroid Association Clinical Management Guideline on Active Surveillance for Low-Risk Papillary Thyroid Carcinoma
    Eun Kyung Lee, Min Joo Kim, Seung Heon Kang, Bon Seok Koo, Kyungsik Kim, Mijin Kim, Bo Hyun Kim, Ji-hoon Kim, Shinje Moon, Kyorim Back, Young Shin Song, Jong-hyuk Ahn, Hwa Young Ahn, Ho-Ryun Won, Won Sang Yoo, Min Kyoung Lee, Jeongmin Lee, Ji Ye Lee, Kyon
    Endocrinology and Metabolism.2025; 40(3): 307.     CrossRef
  • Current evidence and strategies for preventing tumor recurrence following thermal ablation of papillary thyroid carcinoma
    Ru Li, Luyang Yang, Ming Xu, Baofeng Wu, Qinhao Liu, Qin An, Yuchen Sun, Yi Zhang, Yunfeng Liu
    Cancer Imaging.2025;[Epub]     CrossRef
  • Study Protocol of Expanded Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro-EXP) (Endocrinol Metab 2025;40:236-46, Jae Hoon Moon et al.)
    Eun Kyung Lee, Jae Hoon Moon, Young Joo Park
    Endocrinology and Metabolism.2025; 40(4): 655.     CrossRef
  • The association between composite inflammatory indicators and the clinicopathological characteristics of differentiated thyroid carcinoma
    Li-Yuan Yang, Li-Peng Yang
    Frontiers in Molecular Biosciences.2025;[Epub]     CrossRef
  • Sorveglianza attiva nei noduli tiroidei: pro e contro
    Giulia Brigante, Gloria Agrimonti, Nicolò Bacchi, Francesco Costantino, Roberta Sueri, Vincenzo Rochira, Manuela Simoni
    L'Endocrinologo.2025; 26(5): 623.     CrossRef
  • Microwave Ablation versus Surgery for Low-Risk Papillary Thyroid Cancer: Comparable Long-Term Oncologic Outcomes
    Iram Hussain
    Clinical Thyroidology®.2025; 37(9): 328.     CrossRef
  • The effect of thyroid nodule location in ultrasound on the diagnosis of papillary thyroid carcinoma
    Jia-fei Hu, Jun Xu, Li-ping Gao, Xiao-lin Shen, Yan-li Wang, Min-juan Wu, Ling Zhang
    Discover Oncology.2025;[Epub]     CrossRef
  • Low-risk thyroid cancer: surgery or active surveillance—an application of shared decision-making: a narrative review
    Min Joo Kim, Eun Kyung Lee, Sun Wook Cho, Yoo Hyung Kim, Kyu Eun Lee, Su-jin Kim, Woochul Kim, Eun-Jae Chung, Jungirl Seok, Yul Hwangbo, Young Ki Lee, Jinsun Jang, Junsun Ryu, Yuh-Seog Jung, Chang Hwan Ryu, Jae Hoon Moon, June Young Choi, Hyeong Won Yu, K
    Journal of the Korean Medical Association.2025; 68(9): 573.     CrossRef
  • Thyroid Cancer: Pathogenesis, Clinicopathology, Diagnosis, and Management
    Yu‐Dong Li, Qing‐Yao Ye, Yan‐Xing Chen, Xia‐Rong Hu
    MedComm.2025;[Epub]     CrossRef
  • A national survey of physicians regarding active surveillance for low-risk thyroid cancer in Korea
    Min Joo Kim, Jae Hoon Moon, Eun Kyung Lee, Young Shin Song, Kyong Yeun Jung, Ji Ye Lee, Ji-hoon Kim, Woojin Lim, Kyungsik Kim, Sue K. Park, Young Joo Park
    European Thyroid Journal.2025;[Epub]     CrossRef
  • 2023 Update of the Korean Thyroid Association Guidelines for the Management of Thyroid Nodules
    Eun Kyung Lee, Young Joo Park
    Clinical Thyroidology®.2024; 36(4): 153.     CrossRef
  • Association between exercise habits and incident type 2 diabetes mellitus in patients with thyroid cancer: nationwide population-based study
    Jiyun Park, Jin-Hyung Jung, Hyunju Park, Young Shin Song, Soo-Kyung Kim, Yong-Wook Cho, Kyungdo Han, Kyung-Soo Kim
    BMC Medicine.2024;[Epub]     CrossRef
  • Prediction of Recurrent Laryngeal Nerve Invasion in Thyroid Cancer by Ultrasound
    Jin Hyang Jung, Eunji Kim, Byung Ju Kang
    Journal of Surgical Ultrasound.2024; 11(1): 18.     CrossRef
  • Advances in clinical research on ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma
    Hua Xu, Jin-yan Yang, Xing Zhao, Zhe Ma
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Systemic therapy for differentiated thyroid cancer with distant metastasis
    Eun Kyung Lee
    Journal of the Korean Medical Association.2024; 67(7): 484.     CrossRef
Close layer
Thyroid
The Concept of Economic Evaluation and Its Application in Thyroid Cancer Research
Kyungsik Kim, Mijin Kim, Woojin Lim, Bo Hyun Kim, Sue K. Park
Endocrinol Metab. 2021;36(4):725-736.   Published online August 27, 2021
DOI: https://doi.org/10.3803/EnM.2021.1164
  • 10,413 View
  • 185 Download
  • 5 Web of Science
  • 6 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Economic evaluation is a type of comparative analysis between interventions in terms of both their resource use and health outcomes. Due to the good prognosis of thyroid cancer (TC), the socioeconomic burden of TC patients post-diagnosis is increasing. Therefore, economic evaluation studies focusing on TC are recommended. This study aimed to describe the concept and methods of economic evaluation and reviewed previous TC studies. Several previous studies compared the costs of interventions or evaluated recurrence, complications, or quality of life as measures of their effectiveness. Regarding costs, most studies focused on direct costs and applied hypothetical models. Cost-minimization analysis should be distinguished from simple cost analysis. Furthermore, due to the universality of the term “cost-effectiveness analysis” (CEA), several studies have not distinguished CEA from cost-utility analysis; this point needs to be considered in future research. Cost-benefit analyses have not been conducted in previous TC research. Since TC has a high survival rate and good prognosis, the need for economic evaluations has recently been pointed out. Therefore, correct concepts and methods are needed to obtain clear economic evaluation results. On this basis, it will be possible to provide appropriate guidelines for TC treatment and management in the future.

Citations

Citations to this article as recorded by  
  • Financial Toxicity Across the Thyroid Cancer Care Continuum: A Systematic Review
    Maria Armache, Rachel Stemme, Wassim Najjar, Nadia L. Samaha, Madison Hearn, Stefany Lazieh, Emily Joseph, Kaitlyn Frazier, Douglas Ball, Jonathon O. Russell, Carole Fakhry, Laila A. Gharzai, Leila J. Mady
    Otolaryngology–Head and Neck Surgery.2025; 173(1): 1.     CrossRef
  • Cost-Utility Analysis of Early Detection with Ultrasonography of Differentiated Thyroid Cancer: A Retrospective Study on a Korean Population
    Han-Sang Baek, Jeonghoon Ha, Kwangsoon Kim, Ja Seong Bae, Jeong Soo Kim, Sungju Kim, Dong-Jun Lim, Chul-Min Kim
    Endocrinology and Metabolism.2024; 39(2): 310.     CrossRef
  • Role of Prehabilitation and Rehabilitation on Functional Recovery and Quality of Life in Thyroid Cancer Patients: A Comprehensive Review
    Lorenzo Lippi, Alessio Turco, Stefano Moalli, Marco Gallo, Claudio Curci, Antonio Maconi, Alessandro de Sire, Marco Invernizzi
    Cancers.2023; 15(18): 4502.     CrossRef
  • Sex-specific Associations between Body Mass Index and Thyroid Cancer Incidence among Korean Adults
    Kyoung-Nam Kim, Kyungsik Kim, Sangjun Lee, Sue K. Park
    Cancer Epidemiology, Biomarkers & Prevention.2023; 32(9): 1227.     CrossRef
  • Active Surveillance Versus Immediate Surgery for Low-Risk Papillary Thyroid Microcarcinoma Patients in South Korea: A Cost-Minimization Analysis from the MAeSTro Study
    Kyungsik Kim, June Young Choi, Su-jin Kim, Eun Kyung Lee, Young Ki Lee, Jun Sun Ryu, Kyu Eun Lee, Jae Hoon Moon, Young Joo Park, Sun Wook Cho, Sue K. Park
    Thyroid.2022; 32(6): 648.     CrossRef
  • A Systematic Review of Economic Evaluation of Thyroid Cancer
    Mijin Kim, Woojin Lim, Kyungsik Kim, Ja Seong Bae, Byung Joo Lee, Bon Seok Koo, Eun Kyung Lee, Eu Jeong Ku, June Young Choi, Bo Hyun Kim, Sue K. Park
    International Journal of Thyroidology.2022; 15(2): 74.     CrossRef
Close layer
Original Articles
Thyroid
Association between Iodine Intake, Thyroid Function, and Papillary Thyroid Cancer: A Case-Control Study
Kyungsik Kim, Sun Wook Cho, Young Joo Park, Kyu Eun Lee, Dong-Wook Lee, Sue K. Park
Endocrinol Metab. 2021;36(4):790-799.   Published online August 11, 2021
DOI: https://doi.org/10.3803/EnM.2021.1034
  • 12,126 View
  • 305 Download
  • 28 Web of Science
  • 32 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
This study aimed to assess the effects of iodine intake, thyroid function, and their combined effect on the risk of papillary thyroid cancer (PTC) and papillary thyroid microcarcinoma (PTMC).
Methods
A case-control study was conducted including 500 community-based controls who had undergone a health check-up, and 446 overall PTC cases (209 PTC and 237 PTMC) from the Thyroid Cancer Longitudinal Study. Urinary iodine concentration (UIC), was used as an indicator of iodine intake, and serum for thyroid function. The risk of PTC and PTMC was estimated using unconditional logistic regression.
Results
Excessive iodine intake (UIC ≥220 μg/gCr) was associated with both PTC (odds ratio [OR], 18.13 95% confidence interval [CI], 8.87 to 37.04) and PTMC (OR, 8.02; 95% CI, 4.64 to 13.87), compared to adequate iodine intake (UIC, 85 to 219 μg/gCr). Free thyroxine (T4) levels ≥1.25 ng/dL were associated with PTC (OR, 1.97; 95% CI, 1.36 to 2.87) and PTMC (OR, 2.98; 95% CI, 2.01 to 4.41), compared to free T4 levels of 0.7 to 1.24 ng/dL. Individuals with excessive iodine intake and high free T4 levels had a greatly increased OR of PTC (OR, 43.48; 95% CI, 12.63 to 149.62), and PTMC (OR, 26.96; 95% CI, 10.26 to 70.89), compared to individuals with adequate iodine intake and low free T4 levels.
Conclusion
Excessive iodine intake using creatinine-adjusted UIC and high free T4 levels may have a synergistic effect on PTC and PTMC. Considering both iodine intake and thyroid function is important to assess PTC and PTMC risk.

Citations

Citations to this article as recorded by  
  • Thyroid cancer in Asia: incidence, mortality in 2022, and future projections to 2050
    Mengxia Fu, Zhiming Peng, Min Wu
    European Journal of Cancer Prevention.2026; 35(2): 126.     CrossRef
  • Association of iodine nutritional status with thyroid nodules and papillary thyroid carcinoma in women from an iodine-sufficient region in Brazil: A cross-sectional center study
    Ivia Fonseca, Aline Larcher de Almeida, Patrícia Borges dos Santos, Natalia Treistman, Tales Aprigio, Mario Vaisman, Ana Paula Aguiar Vidal, Patrícia de Fátima dos Santos Teixeira, Nathalie Silva de Morais
    Journal of Trace Elements in Medicine and Biology.2026; 93: 127816.     CrossRef
  • Enhancing CEUS Value in Papillary Thyroid Carcinoma: A Dual-Model Framework for Patient Selection Based on Conventional Ultrasound Characteristics
    Liyuan He, Yinghua Li, Delin Zhong, Jing Gao, Yuan Yuan, Shuhuan Zhang, Jianyuan Wang
    Ultrasound in Medicine & Biology.2026; 52(3): 714.     CrossRef
  • Dietary and Urinary Iodine in Relation to Thyroid Cancer Risk: A Meta-Analysis
    Shitao Li, Hengxu Yu
    Cancer Control.2026;[Epub]     CrossRef
  • Environmental Risk Factors and Thyroid Cancer: An Integrative Review and Future Directions
    Muneer Nusir, Sajid Ullah Khan
    International Journal of Computational Intelligence Systems.2026;[Epub]     CrossRef
  • Effects of iodinated copper-based foliar fertilizers on iodine content, yield and quality of lettuce (Lactuca sativa L.)
    Anmeng Liu, Guobo Sun, Guofeng Ma, Min Zhang, Zhiguang Liu, Lingyun Tang
    Frontiers in Plant Science.2026;[Epub]     CrossRef
  • Conditional survival disparities and determinants in Urban-Rural patients with papillary thyroid carcinoma
    Xiaoyu Ji, Ruonan Yu, Yue Yu, Ping Zhang, Wenwu Dong, Hao Zhang
    Endocrine.2026;[Epub]     CrossRef
  • Incidental thyroid carcinoma in surgically treated multinodular goiter: a retrospective study
    G. Pavone, E. Lamanna, M. Pacilli, E. Khoury, A. Ambrosi, N. Tartaglia
    Frontiers in Surgery.2026;[Epub]     CrossRef
  • Risk factors associated with aggressive tumor phenotypes in papillary thyroid microcarcinoma: a systematic review and meta-analysis
    Máté Orgoványi, Anett Rancz, Anca Dolhascu, Gergely Agócs, Boglárka Lilla Szentes, Emese Sipter, Péter Hegyi, Gábor László Kovács
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Long-Term Trends in Thyroid Cancer Incidence and Mortality in Korea: Analysis of Korean National Data
    Yu Jeong Yoon, Jeong Min Seo, Jin Seob Kim, Yun Mi Choi, Won Gu Kim
    Endocrinology and Metabolism.2026;[Epub]     CrossRef
  • Biological Consequences and HPT-Axis Dysregulation Under Extreme Iodine Exposure in Zebrafish: Implications for Thyroid Function, Behaviour and Pathophysiology
    Sreejith Pongillyathundi Sasidharan, Induprabha Yadev, Rajamony Chellammal Arun Dileep, Anoop Manakkadan, Thadiyan Parambil Ijinu
    Journal of Trace Elements and Minerals.2026; : 100322.     CrossRef
  • Continued rise in the incidence of thyroid cancer in Iran: true increase or overdiagnosis?
    Mahnaz Pejman Sani, Shahrzad Mohseni, Hilda Samimi, Shirzad Nasiri, Babak Fallahi, Mohammadreza Mohajeri-Tehrani, Seyed Mohammad Tavangar, Mahmood Naderi, Nooshin Shirzad, Bagher Larijani, Sayed Mahmoud Sajjadi-Jazi, Gholamreza Roshandel, Vahid Haghpanah
    Journal of Diabetes & Metabolic Disorders.2025;[Epub]     CrossRef
  • Heavy metals in seaweed: Implications for health benefits, risks, and safety regulations
    Lori Huang, Ji-Young Lee, Young-Ki Park, Jaeeun Lee
    Journal of Agriculture and Food Research.2025; 21: 101830.     CrossRef
  • The association between per-fluoroalkyl and poly-fluoroalkyl substances exposure and thyroid cancer: a meta-analysis
    Ruyu Wang, Mengze Lv, Siqi Chen, Yueran Zheng, Zeyuan Fu, Xupu Yang, Jingjing Wang, Qianyu Liu, Yi Liu, Xiaolin Zhang, Huicai Guo, Xuehui Liu
    Journal of Environmental Health Science and Engineering.2025;[Epub]     CrossRef
  • Bridging the deficit: Assessing knowledge gaps in thyroid cancer management amongst physicians in the Democratic Republic of Congo
    John Bukasa-Kakamba, Ayrton I Bangolo, Nickson Poka, Christian Bompongo, Shruti Wadhwani, Nikita Wadhwani, Isis Kapinga Kalambayi, Manasse Bukasa Mutombo, Pierre Fwelo, Pascal Bayauli, Gael Menga, Andy Sifa, Cute Diazabakana, Guy Kingebeni, Mbuyi Mulumba,
    World Journal of Clinical Oncology.2025;[Epub]     CrossRef
  • Risks of Iodine Excess
    Seo Young Sohn, Kosuke Inoue, Connie M Rhee, Angela M Leung
    Endocrine Reviews.2024; 45(6): 858.     CrossRef
  • The influence of micronutrients and macronutrients excess or deficiency on thyroid function
    K. Brzdęk, S. Wiśniewski, O. Domańska, W. Baran, M. Brzdęk
    The Ukrainian Biochemical Journal.2024; 96(4): 5.     CrossRef
  • Association between Thyroid Profile Levels and Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Retrospective Study
    Yu-Shan Hsieh, Ting-Teng Yang, Chung-Huei Hsu, Yan-Yu Lin
    Reports.2024; 7(3): 78.     CrossRef
  • Consequences of acute and long‐term excessive iodine intake: A literature review focusing on seaweed as a potential dietary iodine source
    Marthe Jordbrekk Blikra, Inger Aakre, Jessica Rigutto‐Farebrother
    Comprehensive Reviews in Food Science and Food Safety.2024;[Epub]     CrossRef
  • Iodine Excess Is Associated with Thyroid Dysfunction Among the Elderly
    Qi Jin, Zhangzhao Wang, Junjing Li, Hexi Zhang, Mengxin Liu, Chunxi Wang, Wenxing Guo, Wanqi Zhang
    Biological Trace Element Research.2024; 203(7): 3470.     CrossRef
  • Association between urinary iodine concentration and the risk of papillary thyroid cancer by sex and age: a case–control study
    Yerin Hwang, Hyun-Kyung Oh, Jae Hoon Chung, Sun Wook Kim, Jung-Han Kim, Jee Soo Kim, Myung-Hee Shin
    Scientific Reports.2023;[Epub]     CrossRef
  • Association between iodine nutrition and cervical lymph node metastasis of papillary thyroid microcarcinoma
    Hengqiang Zhao, Jin Hu, Le Cui, Yiping Gong, Tao Huang
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Sex-specific Associations between Body Mass Index and Thyroid Cancer Incidence among Korean Adults
    Kyoung-Nam Kim, Kyungsik Kim, Sangjun Lee, Sue K. Park
    Cancer Epidemiology, Biomarkers & Prevention.2023; 32(9): 1227.     CrossRef
  • Nomogram Model Based on Iodine Nutrition and Clinical Characteristics of Papillary Thyroid Carcinoma to Predict Lateral Lymph Node Metastasis
    Junrong Wang, Yuzhang Gao, Yuxuan Zong, Weitong Gao, Xueying Wang, Ji Sun, Susheng Miao
    Cancer Control.2023;[Epub]     CrossRef
  • Content of Copper, Iron, Iodine, Rubidium, Strontium and Zinc in Thyroid Malignant Nodules and Thyroid Tissue adjacent to Nodules
    Vladimir Zaichick, Qiping Dong
    Journal of Clinical and Diagnostic Pathology.2022; 1(4): 7.     CrossRef
  • Distinguish Thyroid Malignant from Benign Alterations using Trace Element Contents in Nodular Tissue determined by Neutron Activation and Inductively Coupled Plasma Mass Spectrometry
    Vladimir Zaichick
    Journal of Clinical and Diagnostic Pathology.2022; 1(4): 18.     CrossRef
  • Seaweed and Iodine Intakes and SLC5A5 rs77277498 in Relation to Thyroid Cancer
    Tung Hoang, Eun Kyung Lee, Jeonghee Lee, Yul Hwangbo, Jeongseon Kim
    Endocrinology and Metabolism.2022; 37(3): 513.     CrossRef
  • Iodine nutrition and papillary thyroid cancer
    Xueqi Zhang, Fan Zhang, Qiuxian Li, Chuyao Feng, Weiping Teng
    Frontiers in Nutrition.2022;[Epub]     CrossRef
  • The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis
    Xueqi Zhang, Fan Zhang, Qiuxian Li, Renaguli Aihaiti, Chuyao Feng, Deshi Chen, Xu Zhao, Weiping Teng
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Screening and validation of lymph node metastasis risk-factor genes in papillary thyroid carcinoma
    Qiaoyue Zhang, Jing Li, Hengyan Shen, Xinyu Bai, Tao Zhang, Ping Liu
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Diagnosis of Thyroid Malignancy using Levels of Chemical Element Contents in Nodular Tissue
    Vladimir Zaichick
    Journal of Health Care and Research.2022; 3(1): 16.     CrossRef
  • Associations of Habitual Mineral Intake with New-Onset Prediabetes/Diabetes after Acute Pancreatitis
    Claire F. Norbitt, Wandia Kimita, Juyeon Ko, Sakina H. Bharmal, Maxim S. Petrov
    Nutrients.2021; 13(11): 3978.     CrossRef
Close layer
Clinical Study
Effects of Maternal Iodine Status during Pregnancy and Lactation on Maternal Thyroid Function and Offspring Growth and Development: A Prospective Study Protocol for the Ideal Breast Milk Cohort
Young Ah Lee, Sun Wook Cho, Ho Kyung Sung, Kyungsik Kim, Young Shin Song, Sin Je Moon, Jung Won Oh, Dal Lae Ju, Sooyeon Choi, Sang Hoon Song, Gi Jeong Cheon, Young Joo Park, Choong Ho Shin, Sue K. Park, Jong Kwan Jun, June-Key Chung
Endocrinol Metab. 2018;33(3):395-402.   Published online September 18, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.3.395
  • 10,718 View
  • 113 Download
  • 5 Web of Science
  • 5 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Iodine is an intrinsic element of thyroid hormone, which is essential for childhood growth and development. The Ideal Breast Milk (IBM) cohort study aims to evaluate the effects of maternal iodine status during pregnancy and lactation on maternal thyroid function, offspring growth and development, and offspring thyroid function.

Methods

The IBM cohort study recruited pregnant women from Seoul National University Hospital between June 2016 and August 2017, followed by enrollment of their offspring after delivery. For the maternal participants, iodine status is evaluated by urinary iodine concentration (UIC) and dietary records in the third trimester and at 3 to 4 weeks and 12 to 15 months postpartum. For the child participants, cord blood sampling and UIC measurements are performed at birth. At 3 to 4 weeks of age, UIC and breastmilk iodine concentrations are measured. At 12 to 15 months of age, growth and development are assessed and measurements of UIC, a thyroid function test, and ultrasonography are performed.

Results

A total of 198 pregnant women in their third trimester were recruited. Their mean age was 35.1±3.5 years, and 78 (39.4%) of them were pregnant with twins. Thirty-three (16.7%) of them had a previous history of thyroid disease.

Conclusion

Korea is an iodine-replete area. In particular, lactating women in Korea are commonly exposed to excess iodine due to the traditional practice of consuming brown seaweed soup postpartum. The study of the IBM cohort is expected to contribute to developing guidelines for optimal iodine nutrition in pregnant or lactating women.

Citations

Citations to this article as recorded by  
  • Prenatal PFAS Exposure in a Twin Pregnancy Cohort: Associations with Thyroid Disruption, Placental Malperfusion, and Fetal Growth Restriction
    Heeyeon Chae, Eun Na Kim, Na-Youn Park, Inae Lee, Young Ah Lee, Jong Kwan Jun, Gi Jeong Cheon, Young Joo Park, Younglim Kho, Sun Wook Cho, Kyungho Choi
    Environmental Science & Technology.2026; 60(23): 16435.     CrossRef
  • Investigating Birth and Thyroid Outcomes of Maternal-Fetal Environmental Exposures (IBM-E): A Cohort Protocol for Dietary Iodine and Endocrine Disruptors
    Yun Ji Jung, Jeong Eun Shin, Ju-hee Yoon, Suhra Kim, Hayan Kwon, Sungbo Shim, Dong Yeob Shin, Minseo Gim, Younglim Kho, JoonHo Lee
    Endocrinology and Metabolism.2025; 40(6): 940.     CrossRef
  • Exposure to and Transplacental Transfer of Per- and Polyfluoroalkyl Substances in a Twin Pregnancy Cohort in Korea
    Na-Youn Park, Sun Wook Cho, Ye Eun Seo, Heeyeon Chae, Inae Lee, Young Ah Lee, Jong Kwan Jun, Eun Na Kim, Jeong-Won Oh, Kyungho Choi, Younglim Kho
    Environmental Science & Technology.2024; 58(48): 21120.     CrossRef
  • High intakes of iodine among women during pregnancy and the postpartum period has no adverse effect on thyroid function
    Dal Lae Ju, Sun Wook Cho, Chae Won Chung, Young Ah Lee, Gi Jeong Cheon, Young Joo Park, Choong Ho Shin, Jong Kwan Jun, June-Key Chung, Sue K. Park, YoonJu Song
    European Journal of Nutrition.2023; 62(1): 239.     CrossRef
  • Associations between maternal thyroid function in pregnancy and child neurodevelopmental outcomes at 20 months in the Seychelles Child Development Study, Nutrition Cohort 2 (SCDS NC2)
    Anna M. Monaghan, Maria S. Mulhern, Emeir M. Mc Sorley, J.J. Strain, Theresa Winter, Edwin van Wijngaarden, Gary J. Myers, Philip W. Davidson, Conrad Shamlaye, Jude Gedeon, Alison J. Yeates
    Journal of Nutritional Science.2021;[Epub]     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP